Evidence map›Paper›PMID 19015167›Full record

ReviewToxicological sciences : an official journal of the Society of Toxicology2009

Arsenic and cardiovascular disease.

J Christopher States, Sanjay Srivastava, Yu Chen, Aaron Barchowsky

Abstract readReview
In one paragraph

Review in Toxicological sciences : an official journal of the Society of Toxicology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 6 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 6 syntheses or guidelines pooled it, 349 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Metabolic Derangement by Arsenic: a Review of the Mechanisms.Biological trace element research · 2024
    Review
  20. Review

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

J Christopher StatesDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky 40292, USA. jcstates@louisville.edu
Sanjay Srivastava
Yu Chen
Aaron Barchowsky
University of Pittsburgh · USUniversity of Louisville · US

Funding

Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAMT32ES011564 · NIEHS · UNIVERSITY OF LOUISVILLE · PI David W Hein, John Pierce Wise · 2004 to 2026
$7.1M
Role of Platelet Activation and Vascular Pathology in Aldehyde ToxicityP01ES011860 · NIEHS · UNIVERSITY OF LOUISVILLE · PI PIERCE, WILLIAM M · 2003 to 2007
$7.0M
Strategic Vision & Impact on Environmental HealthP30ES014443 · NIEHS · UNIVERSITY OF LOUISVILLE · PI RAMOS, IRMA N · 2007 to 2010
$4.4M
Mechanisms for Arsenic-Induced Vascular DiseaseR01ES013781 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BARCHOWSKY, AARON · 2008 to 2012
$2.5M
Atherogenic Mechanisms of ArsenicR01ES017260 · NIEHS · UNIVERSITY OF LOUISVILLE · PI SRIVASTAVA, SANJAY · 2009 to 2013
$1.6M
Metabolism and Detoxification of Base PropenalsR01ES011594 · NIEHS · UNIVERSITY OF LOUISVILLE · PI SRIVASTAVA, SANJAY · 2003 to 2007
$1.6M
Arsenic Induced Miotic Arrest Associated ApoptosisR01ES011314 · NIEHS · UNIVERSITY OF LOUISVILLE · PI STATES, J CHRISTOPHER · 2003 to 2009
$1.4M
Endothelial Metabolism of Atherogenic AldehydesR01HL065618 · NHLBI · UNIVERSITY OF LOUISVILLE · PI SRIVASTAVA, SANJAY · 2002 to 2005
$1.2M
Transplacental Arsenic Induced Hepatic Dysfunction and Vascular DiseaseR21ES015812 · NIEHS · UNIVERSITY OF LOUISVILLE · PI STATES, J CHRISTOPHER · 2008 to 2010
$417k
Arsenite inhibition of mitotic progressionF30ES013372 · NIEHS · UNIVERSITY OF LOUISVILLE · PI TAYLOR, BEN F · 2004 to 2008
$152k
NHLBI NIH HHS R01HL65618NIEHS NIH HHS F30ES013372NIEHS NIH HHS P01ES11860NIEHS NIH HHS P30ES000260NIEHS NIH HHS P30ES00989NIEHS NIH HHS P30ES014443NIEHS NIH HHS P42ES010349NIEHS NIH HHS R01ES011314NIEHS NIH HHS R01ES011594NIEHS NIH HHS R01 ES013781NIEHS NIH HHS R01ES013781NIEHS NIH HHS R01 ES017260NIEHS NIH HHS R21ES015812NIEHS NIH HHS T32ES011564
6 · The paper itself

Abstract

Chronic arsenic exposure is a worldwide health problem. Although arsenic-induced cancer has been widely studied, comparatively little attention has been paid to arsenic-induced vascular disease. Epidemiological studies have shown that chronic arsenic exposure is associated with increased morbidity and mortality from cardiovascular disease. In addition, studies suggest that susceptibility to arsenic-induced vascular disease may be modified by nutritional factors in addition to genetic factors. Recently, animal models for arsenic-induced atherosclerosis and liver sinusoidal endothelial cell dysfunction have been developed. Initial studies in these models show that arsenic exposure accelerates and exacerbates atherosclerosis in apolipoprotein E-knockout mice. Microarray studies of liver mRNA and micro-RNA abundance in mice exposed in utero suggest that a permanent state of stress is induced by the arsenic exposure. Furthermore, the livers of the arsenic-exposed mice have activated pathways involved in immune responses suggesting a pro-hyperinflammatory state. Arsenic exposure of mice after weaning shows a clear dose-response in the extent of disease exacerbation. In addition, increased inflammation in arterial wall is evident. In response to arsenic-stimulated oxidative signaling, liver sinusoidal endothelium differentiates into a continuous endothelium that limits nutrient exchange and waste elimination. Data suggest that nicotinamide adenine dinucleotide phosphate oxidase-derived superoxide or its derivatives are essential second messengers in the signaling pathway for arsenic-stimulated vessel remodeling. The recent findings provide future directions for research into the cardiovascular effects of arsenic exposure.

Indexed as

AnimalsApolipoproteins EArsenicArsenic PoisoningAtherosclerosisCardiovascular DiseasesEndoplasmic ReticulumEnvironmental ExposureHemodynamicsHumansMiceMice, KnockoutOxidative StressVasculitisApolipoproteins EArsenic

Identifiers

PMID19015167
PMCPMC2639760
OpenAlexW2168739412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.